Injection pen casing
Latest BOEHRINGER INGELHEIM INTERNATIONAL GMBH Patents:
- Dioxane derivatives
- Biomarkers associated with anti-IL-36R antibody treatment in generalized pustular psoriasis
- Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product
- Soluble guanylate cyclate activators for treating systemic sclerosis
- Antibodies to connective tissue growth factor (CTGF) and uses thereof
Description
The broken lines show portions of the design that form no part of the claimed design.
Claims
The ornamental design for an injection pen casing, as shown and described.
Referenced Cited
U.S. Patent Documents
| D677380 | March 5, 2013 | Julian |
| D694879 | December 3, 2013 | Julian |
| 8945067 | February 3, 2015 | McLoughlin |
| D758568 | June 7, 2016 | Wohlfahrt |
| D758570 | June 7, 2016 | Wohlfahrt |
| D774641 | December 20, 2016 | Miggels |
| D866752 | November 12, 2019 | Rogge |
| 20130041328 | February 14, 2013 | Daniel |
| 20130150797 | June 13, 2013 | Lesch, Jr. |
| 20170304538 | October 26, 2017 | Renstad |
| 20170312457 | November 2, 2017 | Desalvo |
| 20190247589 | August 15, 2019 | Holmqvist |
| 20190351139 | November 21, 2019 | Sarkorov |
Patent History
Patent number: D915584
Type: Grant
Filed: Jul 15, 2019
Date of Patent: Apr 6, 2021
Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Ingelheim)
Inventors: Arthur Eisenkrein (Essen), Oliver Koszel (Essen), Axel Roth (Mainz)
Primary Examiner: Nathan M Johnston
Application Number: 29/698,213
Type: Grant
Filed: Jul 15, 2019
Date of Patent: Apr 6, 2021
Assignee: BOEHRINGER INGELHEIM INTERNATIONAL GMBH (Ingelheim)
Inventors: Arthur Eisenkrein (Essen), Oliver Koszel (Essen), Axel Roth (Mainz)
Primary Examiner: Nathan M Johnston
Application Number: 29/698,213
Classifications